All In Biotech

Free tool

FAERS Monitor: Felbatol

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020189 or its brand name (Felbatol, Felbamate). Reports on generic versions are filed under their own applications.

Reports

1,779

Serious

1,266

71% of reports

Hospitalization

550

Death reported

89

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • seizure364
  • drug ineffective263
  • off label use134
  • convulsion124
  • somnolence114
  • condition aggravated92
  • fatigue87
  • drug interaction73
  • vomiting72
  • toxicity to various agents71
  • generalised tonic-clonic seizure68
  • diarrhoea61
  • fall61
  • weight decreased57
  • pneumonia52

Reports by year received

View as table
YearReports
200410
20057
200623
200718
200811
200915
201030
201138
201273
201377
201498
2015128
2016113
201791
2018104
2019128
2020155
2021163
2022119
202383
2024111
2025128
202656

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,380 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
generalised tonic-clonic seizureSignal6848.838.63,124
seizureSignal36437.434.112,879
convulsionSignal12425.721.72,919
somnolenceSignal1146.75.6552
drug interactionSignal735.44.3262
toxicity to various agentsSignal715.04.0224
condition aggravatedSignal923.62.9171
weight decreasedSignal572.41.946
drug ineffectiveSignal2632.42.1218
fallSignal612.21.738
pneumonia521.91.522
vomiting721.81.426
off label use1341.81.550
fatigue871.31.17
diarrhoea611.10.91

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.